A phase II study of irinotecan with 5-fluorouracil and leucovorin in patients with previously untreated gastric adenocarcinoma

Annals of Oncology

Volumn 12, Issue 11, 2001, Pages 1575-1580

  Blanke, C D ^a   Haller, D G ^b   Benson, A B ^c   Rothenberg, M L ^d   Berlin, J ^d   Mori, M ^e   Hsieh, Y Ch ^e   Miller, L L ^f  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d VANDERBILT INGRAM CANCER CENTER   (United States)

^e Health and Sciences Center   (United States)

^f PFIZER INC   (United States)

Author keywords

5 fluoruracil; Gastric cancer; Irinotecan; Leucovorin

Indexed keywords

FLUOROURACIL; FOLINIC ACID; IRINOTECAN;

ADULT; ADVANCED CANCER; AGED; ANEMIA; ANOREXIA; ARTICLE; BOLUS INJECTION; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; ESOPHAGITIS; FEBRILE NEUTROPENIA; FEMALE; HUMAN; HUMAN CELL; INFECTION; LOWER ESOPHAGUS SPHINCTER; MALE; NAUSEA AND VOMITING; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RECURRENT CANCER; REST; SEPSIS; STOMACH ADENOCARCINOMA; THROMBOEMBOLISM; TREATMENT PLANNING;

EID: 0035692526     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1013129315036     Document Type: Article

References (28)

1. Phase II-III chemotherapy studies in advanced gastric cancer
2. Integration of chemotherapy into combined modality treatment of solid tumors
3. Phase II trial of etoposide (VP-16) in the treatment of upper gastrointestinal malignancies
4. Phase II clinical trial of cisdichlorodiommineplatinum in gastric cancer
5. Phase II study of Taxol in patients with advanced gastric carcinoma
6. Phase II trial of taxol in patients with adenocarcinoma of the upper gastrointestinal tract. The Eastern Cooperative Oncology group results
7. 5-fluorouracil, doxorubicin and mitomycin (FAM) combination chemotherapy for advanced gastric cancer
8. Long-term results with FAMTX in advanced gastric cancer
9. Long-term survival after epirubicin, cisplatin, and fluorouracil for gastric cancer: Results of a randomized trial
10. Standard chemotherapy for gastric carcinoma: Is it a myth?
11. Antileukemic activity of new camptothecin derivatives
12. Antitumor activity of newly synthesized, lactone ring-closed and water-soluble camptothecin derivative in mice
13. Antitumor activity of 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxy-camptothecin, a novel water-soluble derivative of camptothecin, against murine tumors
14. Late phase II study of irinotecan hydrochloride (CPT-11) in advanced gastric cancer
15. A phase I clinical and pharmacokinetic study of irinotecan hydrochloride (CPT-11), 5-fluorouracil, and leucovorin in patients with advanced solid tumors
16. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer
17. Phase II trial of irinotecan in patients with progressive or rapidly recurrent colorectal cancer
18. Irinotecan (CPT-11) high-dose escalation using intensive high-dose loperamide to control diarrhea
19. Optimal two-stage design for phase II clinical trials
20. Irinotecan (CPT-11) in the treatment of advanced gastric cancer: A late phase II study
21. Phase II study of a combination of irinotecan and cisplatin against metastatic gastric cancer
22. Phase I-II study of irinotecan hydrochloride combined with cisplatin in patients with advanced gastric cancer
23. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: A multicentre randomised trial
24. Irinotecan in combination with CDDP or 5-FU and folinic acid is active in patients with advanced gastric or gastro-oesophageal junction carcinoma: Final resuults of a randomised phase II study
25. Phase II study of irinotecan, leucovorin and 5-FU in advanced gastric cancer
26. Irinotecan and cisplatin in advanced gastric or gastroesophageal junction carcinoma
27. Phase II trial of weekly irinotecan plus cisplatin in advanced esophageal cancer
28. Phase II trial of weekly irinotecan + cisplatin in advanced gastric cancer